Phospho-YAP1 (Ser127) Antibody

Basic Research Questions

• What is Phospho-YAP1 (Ser127) and why is it significant in research?

Phospho-YAP1 (Ser127) refers to the Yes-Associated Protein 1 (YAP1) when phosphorylated at the serine residue at position 127. This specific phosphorylation is a critical regulatory mechanism in the Hippo signaling pathway. When YAP1 is phosphorylated at Ser127 by LATS1/2 kinases, it becomes sequestered in the cytoplasm, preventing its nuclear translocation and subsequent transcriptional activity . This phosphorylation represents a key inactivation mechanism for YAP1, effectively shutting down its function as a transcriptional co-activator. The significance of this phosphorylation extends to multiple biological contexts including development, tissue homeostasis, and cancer, making antibodies that specifically detect this modification invaluable research tools for studying Hippo pathway dynamics and YAP1 regulation .

• How does the Hippo signaling pathway regulate YAP1 phosphorylation?

The Hippo signaling pathway regulates YAP1 phosphorylation through a kinase cascade that ultimately controls YAP1 activity and localization. The core pathway involves STK3/MST2 and STK4/MST1 kinases working with their regulatory partner SAV1 . These kinases phosphorylate and activate LATS1/2 kinases, which function in complex with their regulatory protein MOB1. Upon activation, LATS1/2 directly phosphorylate YAP1 at Ser127, creating a binding site for 14-3-3 proteins that sequester YAP1 in the cytoplasm . This cytoplasmic retention prevents YAP1 from entering the nucleus and activating gene expression through interaction with TEAD transcription factors. The pathway responds to various upstream signals including cell density, mechanical stimuli, and cell polarity, ensuring that YAP1 activity is tightly regulated according to cellular context and environmental conditions .

• What applications are Phospho-YAP1 (Ser127) antibodies suitable for?

Phospho-YAP1 (Ser127) antibodies are versatile tools applicable to multiple research techniques. According to manufacturer specifications, these antibodies can be used in Western Blot (WB) analysis with recommended dilutions of 1:500-1:2000, allowing researchers to detect and quantify phosphorylated YAP1 in protein lysates . For Immunohistochemistry (IHC), they work at dilutions of 1:100-1:300, enabling visualization of phospho-YAP1 distribution in tissue sections . Immunofluorescence (IF) applications use dilutions of 1:50-200, providing high-resolution imaging of phospho-YAP1 subcellular localization . Additionally, these antibodies can be utilized in ELISA assays at higher dilutions (1:40000), offering a quantitative method for phospho-YAP1 detection in complex samples . Each application requires specific optimization for the particular experimental system, but these antibodies provide researchers with multiple approaches to investigate YAP1 phosphorylation in various biological contexts.

• How does phosphorylation at Ser127 affect YAP1 subcellular localization?

Phosphorylation at Ser127 fundamentally alters YAP1's subcellular distribution by triggering its cytoplasmic retention. When YAP1 is phosphorylated at this site by LATS1/2 kinases, the modification creates a binding site for 14-3-3 proteins, which sequester YAP1 in the cytoplasm and prevent its nuclear entry . This mechanism directly inhibits YAP1's function as a transcriptional co-activator by physically separating it from its nuclear transcription factor partners, particularly TEADs. The phosphorylation status at Ser127 creates a dynamic localization pattern that responds to various cellular conditions . At low cell density, YAP1 is predominantly nuclear, while at high cell density, increased Hippo pathway activity leads to Ser127 phosphorylation and cytoplasmic translocation . Additionally, interaction with proteins such as AMOT (Angiomotin) isoform 1 can localize phospho-YAP1 to the cytoplasm and tight junctions, further regulating its activity .

Advanced Research Considerations

• What controls should be included when validating Phospho-YAP1 (Ser127) antibody specificity?

Rigorous validation of Phospho-YAP1 (Ser127) antibody specificity requires multiple complementary controls. Primary validation should include phosphatase treatment of samples, which should eliminate antibody binding if the antibody is truly phospho-specific . Researchers should also compare staining patterns between total YAP1 antibody and phospho-specific antibody, expecting differential distribution (cytoplasmic enrichment for phospho-YAP1 versus potential nuclear localization for total YAP1) . Genetic controls are equally critical - samples from YAP1 knockout models should show no signal, while cells with LATS1/2 depletion should display reduced phospho-YAP1 signal . Peptide competition assays using both phosphorylated and non-phosphorylated peptides spanning the Ser127 region (amino acids 93-142) can confirm epitope specificity . Finally, cellular manipulations that alter Hippo pathway activity, such as varying cell density or applying mechanical stress, should produce predictable changes in phospho-YAP1 levels, providing functional validation of antibody performance .

• How can researchers quantify dynamic changes in YAP1 phosphorylation levels?

Quantifying dynamic changes in YAP1 phosphorylation requires complementary approaches to capture both spatial and temporal dimensions. For Western blot analysis, researchers should normalize phospho-YAP1 signal to total YAP1 rather than housekeeping proteins to account for variations in YAP1 expression . Densitometric analysis should be performed across multiple biological replicates with appropriate statistical testing. For immunofluorescence studies, automated image analysis platforms can measure nuclear-to-cytoplasmic ratios of phospho-YAP1 signal across hundreds of individual cells, providing population-level statistics . Time-course experiments should include multiple early timepoints (minutes to hours) to capture rapid phosphorylation changes. For particularly dynamic processes, phospho-proteomic mass spectrometry offers unbiased quantification of multiple YAP1 phosphorylation sites simultaneously . Researchers studying regulatory networks should consider multiplexed approaches that simultaneously monitor phospho-YAP1 and upstream kinases (LATS1/2) or downstream transcriptional targets to correlate phosphorylation status with functional outcomes .

• What are the implications of cross-talk between YAP1 phosphorylation and other post-translational modifications?

YAP1 function is regulated by an intricate network of post-translational modifications that interact with Ser127 phosphorylation. Beyond LATS1/2-mediated Ser127 phosphorylation, YAP1 undergoes multiple additional modifications that influence its stability, localization, and activity . For instance, phosphorylation at Ser-397 by LATS kinases primes YAP1 for subsequent phosphorylation at Ser-400 and Ser-403 by CK1, ultimately triggering ubiquitination by SCF(β-TRCP) E3 ligase and proteasomal degradation . This represents an additional layer of regulation beyond cytoplasmic sequestration. JNK1/2 kinases (MAPK8/9) phosphorylate YAP1 at multiple sites (Thr-119, Ser-138, Thr-154, Ser-367, and Thr-412), specifically regulating its pro-apoptotic functions . More recently identified modifications include lactylation by AARS1, which promotes YAP1 nuclear localization and stabilization, countering the effects of Ser127 phosphorylation . This complex modification network creates a sophisticated code that integrates multiple signaling inputs to fine-tune YAP1 activity in response to diverse cellular conditions and stresses.

• How do mechanical forces and cell density influence YAP1 phosphorylation at Ser127?

Mechanical forces and cell density represent major upstream regulators of YAP1 Ser127 phosphorylation through their effects on Hippo pathway activity. At high cell density, increased cell-cell contacts activate the Hippo pathway, leading to elevated LATS1/2 activity and consequently increased YAP1 Ser127 phosphorylation . This density-dependent regulation ensures appropriate contact inhibition of proliferation. Mechanical forces exert profound effects on YAP1 phosphorylation status through cytoskeletal dynamics . On stiff substrates or under mechanical stretch, decreased Hippo pathway activity results in reduced YAP1 Ser127 phosphorylation, allowing nuclear accumulation and transcriptional activity. This mechanosensing function positions YAP1 as a critical mediator between physical forces and gene expression . In keratinocytes specifically, mechanical strain triggers YAP1 localization to cell membranes, representing an additional regulatory mechanism . The relationship between cell density, mechanical forces, and YAP1 phosphorylation is particularly relevant in contexts of tissue development, wound healing, and fibrosis, where mechanical properties of the microenvironment significantly influence cell behavior .

Methodological Considerations

• What are the recommended sample preparation techniques to preserve YAP1 phosphorylation status?

Preserving YAP1 phosphorylation status during sample preparation requires specific precautions due to the labile nature of phosphorylations. For protein extraction, lysis buffers should consistently include phosphatase inhibitor cocktails (containing sodium fluoride, sodium orthovanadate, β-glycerophosphate, and pyrophosphate) to prevent dephosphorylation during processing . Cold temperature maintenance throughout all preparation steps is critical - samples should remain on ice and centrifugation performed at 4°C. For tissue samples, snap-freezing in liquid nitrogen immediately after collection preserves phosphorylation status far better than chemical fixation . When fixing cells for immunofluorescence, brief (10-15 minute) paraformaldehyde fixation (4%) followed by gentle permeabilization with 0.1-0.2% Triton X-100 maintains phospho-epitope integrity while allowing antibody access . For time-course experiments examining phosphorylation dynamics, researchers should standardize the time between treatment cessation and sample processing, as delays even of minutes can affect phosphorylation levels. Finally, storage conditions matter - extracted proteins should be aliquoted to avoid freeze-thaw cycles and stored at -80°C rather than -20°C for long-term phospho-epitope preservation .

• What optimization strategies improve detection of Phospho-YAP1 (Ser127) in Western blot applications?

Optimizing Western blot detection of Phospho-YAP1 (Ser127) requires attention to multiple technical parameters. Protein extraction should utilize RIPA or NP-40 based buffers with phosphatase inhibitors, and samples should be processed rapidly to minimize dephosphorylation . Regarding sample loading, higher protein amounts (50-80 μg) often improve phospho-YAP1 detection compared to standard loading (20-30 μg) used for total proteins . For gel electrophoresis, 8% acrylamide gels provide optimal resolution for YAP1 (65-78 kDa) . During transfer, using PVDF membranes (rather than nitrocellulose) and methanol-containing transfer buffers improves retention of phosphoproteins . For blocking, 5% BSA in TBST is preferred over milk, as milk contains phosphoproteins that may increase background. Antibody dilution ranges of 1:500-1:2000 in 5% BSA are recommended, with overnight incubation at 4°C to maximize specific binding . Enhanced chemiluminescence (ECL) detection systems with longer exposure times may be necessary, as phospho-specific signals are often weaker than total protein signals. Including appropriate positive controls (cells with activated Hippo pathway) and negative controls (phosphatase-treated samples) in each experiment validates assay performance .

• What are the optimal protocols for immunofluorescence detection of Phospho-YAP1 (Ser127)?

Optimizing immunofluorescence detection of Phospho-YAP1 (Ser127) requires careful attention to fixation, permeabilization, and antibody conditions. For fixation, 4% paraformaldehyde for 10-15 minutes at room temperature preserves phospho-epitopes while maintaining cellular architecture . Methanol fixation should be avoided as it can cause phospho-epitope loss. Permeabilization should be gentle - 0.1-0.2% Triton X-100 for 5-10 minutes provides antibody access while preserving subcellular structures . Blocking with 5% normal serum (from the secondary antibody host species) with 1% BSA reduces background. The Phospho-YAP1 (Ser127) antibody performs optimally at dilutions ranging from 1:50-1:200, with overnight incubation at 4°C allowing maximum specific binding . Counterstaining with total YAP1 antibody from a different host species enables direct comparison of phosphorylated versus total YAP1 distribution. DAPI nuclear staining is essential for evaluating nuclear/cytoplasmic distribution. Confocal microscopy with z-stack acquisition provides the most accurate assessment of subcellular localization . Signal amplification systems like tyramide signal amplification may help detect low abundance phospho-proteins. Finally, automated image analysis measuring cytoplasmic-to-nuclear signal ratios across multiple cells yields quantitative data on phosphorylation-dependent localization changes .

• How can researchers differentiate between phosphorylated and non-phosphorylated YAP1 in complex samples?

Differentiating between phosphorylated and non-phosphorylated YAP1 in complex samples requires complementary analytical approaches. Western blotting provides the most straightforward distinction, as phosphorylated YAP1 typically displays a mobility shift, appearing at a slightly higher molecular weight (65-78 kDa) compared to non-phosphorylated forms . Running parallel samples on Phos-tag acrylamide gels enhances this separation by specifically retarding phosphorylated proteins. Immunoprecipitation with total YAP1 antibody followed by Western blotting with phospho-specific antibody allows enrichment and specific detection of the phosphorylated fraction . For microscopy-based approaches, dual immunofluorescence using phospho-specific and total YAP1 antibodies from different host species can reveal distinct localization patterns - phospho-YAP1 (Ser127) predominantly localizes to the cytoplasm while non-phosphorylated YAP1 often shows nuclear enrichment . Mass spectrometry-based phosphoproteomics offers the highest resolution approach, precisely quantifying the stoichiometry of phosphorylated versus non-phosphorylated peptides at Ser127 and other sites. For functional discrimination, cellular fractionation into nuclear and cytoplasmic compartments followed by Western blotting can correlate phosphorylation status with subcellular distribution .

Advanced Research Applications

• How does YAP1 phosphorylation status influence its interaction with binding partners?

YAP1 phosphorylation at Ser127 fundamentally alters its interactome by creating and disrupting specific protein-protein interactions. The primary consequence of Ser127 phosphorylation is the creation of a binding site for 14-3-3 proteins, which sequester YAP1 in the cytoplasm . This cytoplasmic retention prevents association with nuclear partners, particularly TEAD transcription factors that mediate most of YAP1's transcriptional effects. Phosphorylation also promotes interaction with cytoskeletal and junctional proteins - phospho-YAP1 preferentially binds AMOT (Angiomotin) isoform 1 and AMOTL2, localizing to tight junctions and the cytoplasm . Conversely, Ser127 phosphorylation disrupts interactions with nuclear partners like RUNX and p73 transcription factors. The phosphorylation status also affects interactions with regulatory proteins - for example, the phosphatase PTPN14 induces translocation of YAP1 from nucleus to cytoplasm, potentially through effects on its phosphorylation state . In cancer contexts, mutations in YAP1 or its binding partners that disrupt phosphorylation-dependent interactions can lead to constitutive YAP1 activation. Techniques like BioID or proximity labeling combined with mass spectrometry enable comprehensive mapping of how phosphorylation dynamically reshapes the YAP1 interactome in different cellular contexts .

• What is the relationship between YAP1 phosphorylation and cancer development?

YAP1 phosphorylation at Ser127 represents a critical tumor suppressive mechanism, with dysregulation frequently observed in cancer. Reduced YAP1 Ser127 phosphorylation leads to nuclear accumulation and activation of growth-promoting gene expression programs . In liver and prostate cancers, increased expression of total YAP1 combined with decreased phosphorylation contributes to disease progression . The Hippo pathway components that regulate YAP1 phosphorylation, including LATS1/2 kinases, are frequently inactivated in various cancers, resulting in constitutive YAP1 activation . Several oncogenic processes directly target YAP1 phosphorylation - for example, cytoskeletal alterations in cancer cells can reduce Hippo pathway activity and YAP1 phosphorylation . Mechanistically, unphosphorylated nuclear YAP1 drives expression of genes promoting proliferation, survival, and epithelial-mesenchymal transition (EMT) . YAP1 also regulates the tumor microenvironment through effects on tissue stiffness and mechanotransduction, creating feed-forward loops of activation . Therapeutic strategies targeting this pathway include attempts to restore YAP1 phosphorylation through Hippo pathway activation or directly inhibiting YAP1-TEAD interactions. Monitoring phospho-YAP1 levels provides valuable biomarker information in cancer diagnosis and treatment response prediction .

• How do cell-type specific factors influence YAP1 phosphorylation dynamics?

YAP1 phosphorylation dynamics display remarkable cell-type specificity, reflecting tissue-specific regulation of the Hippo pathway. In epithelial cells, phospho-YAP1 (Ser127) levels are highly responsive to cell density and polarity signals, with strong phosphorylation at high density that localizes YAP1 to the cytoplasm and cell junctions . Keratinocytes show unique sensitivity to mechanical strain, with YAP1 localizing to cell membranes under stretch conditions through mechanisms involving both phosphorylation regulation and direct mechanosensing . In embryonic development, phospho-YAP1 patterns change dramatically - localized mainly to the nucleus in early embryo stages with cytoplasmic redistribution becoming evident at blastocyst and epiblast stages, reflecting developmental timing of Hippo pathway activation . Neurons show specialized regulation, with YAP1 isoforms lacking transactivation domains being particularly abundant in striatal neurons, and altered in conditions like Huntington's disease . Cancer cells frequently display cell-type specific alterations in phospho-YAP1 regulation - liver and prostate cancers show particularly notable dysregulation . These tissue-specific patterns necessitate careful consideration of cellular context when interpreting phospho-YAP1 data, and highlight the importance of using appropriate cell types when modeling Hippo pathway biology in different tissues .

Methodological Troubleshooting

• What are common challenges in detecting Phospho-YAP1 (Ser127) and how can they be addressed?

Detecting Phospho-YAP1 (Ser127) presents several technical challenges that require specific troubleshooting approaches. Weak signal intensity is a common issue due to the transient nature of phosphorylation and relatively low abundance of phospho-proteins . This can be addressed by increasing protein loading (50-80 μg), optimizing antibody concentration (1:500 for Western blot rather than 1:2000), and using signal enhancement systems like high-sensitivity ECL substrates . Phosphate loss during sample preparation is another critical challenge - samples should be processed rapidly with immediate addition of phosphatase inhibitor cocktails, and kept consistently cold . High background in immunoassays often results from non-specific binding - using 5% BSA instead of milk for blocking, increasing wash steps, and titrating antibody concentration can improve signal-to-noise ratio . For immunofluorescence applications where subcellular localization is critical, fixation artifacts may confound interpretation - comparing multiple fixation methods (paraformaldehyde versus methanol) and including cellular treatments that alter phosphorylation status as controls can validate observations . Finally, specificity concerns can be addressed through rigorous validation using phosphatase treatment of parallel samples and peptide competition assays with both phosphorylated and non-phosphorylated peptides spanning the Ser127 region (amino acids 93-142) .